EE86 Healthcare Resource Utilization (HCRU) and Associated Costs Among Patients with Acute Myeloid Leukemia (AML) Treated with Oral Azacitidine as Maintenance and Those Eligible but Not Treated Using a US Claims Database
Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.358
https://www.valueinhealthjournal.com/article/S1098-3015(23)03488-5/fulltext
Section Title :
Section Order :
12384
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03488-5&doi=10.1016/j.jval.2023.09.358